Rosenbaum David P. 4
4 · ARDELYX, INC. · Filed Oct 1, 2024
Insider Transaction Report
Form 4
ARDELYX, INC.ARDX
Rosenbaum David P.
SVP, Drug Development
Transactions
- Sale
Common Stock
2024-09-27$6.92/sh−49,564$342,983→ 301,946 total
Holdings
- 77,592(indirect: By Trust)
Common Stock
- 153,616(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Transaction was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 17, 2024.
- [F2]The shares are directly held by the Reporting Person's wife.
- [F3]The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.